Wednesday, January 7, 2009 - 12:09AM EST

Review Articles

11. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.

Author
Coleman CI; Reinhart K; Kluger J; White CM;
Institution
Journal
Curr Med Res Opin. 2008 May;24(5):1359-62. Epub 2008 Apr 1.
Abstract URL
Click here to view abstract

12. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia.

Author
Steinberg D; Glass CK; Witztum JL;
Institution
Department of Medicine, BSB 1080, University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0682, USA. dsteinberg@ucsd.edu
Journal
Circulation. 2008 Aug 5;118(6):672-7.

13. Familial hypercholesterolemia: current treatment and advances in management.

Author
Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA;
Institution
Academic Medical Center, Department of Vascular Medicine, Meibergreef 9 (Room F4-146), 1105 AZ, Amsterdam, The Netherlands. r.huijgen@amc.uva.nl
Journal
Expert Rev Cardiovasc Ther. 2008 Apr;6(4):567-81.
Abstract URL
Click here to view abstract

14. Ezetimibe: cholesterol lowering and beyond.

Author
Bays HE; Neff D; Tomassini JE; Tershakovec AM;
Institution
Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Avenue, Louisville, KY 40213, USA. hbaysmd@aol.com
Journal
Expert Rev Cardiovasc Ther. 2008 Apr;6(4):447-70.
Abstract URL
Click here to view abstract

15. HDL: still a target for new therapies?

Author
Nicholls SJ;
Institution
Cleveland Clinic, Department of Cardiovascular Medicine, Heart & Vascular Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA. nichols1@ccf.org
Journal
Curr Opin Investig Drugs. 2008 Sep;9(9):950-6.
Abstract URL
Click here to view abstract

16. Hypercholesterolaemia and its management.

Author
Bhatnagar D; Soran H; Durrington PN;
Institution
University of Manchester Cardiovascular Research Group, Core Technology Facility, Manchester M13 9NT. d.bhatnagar@man.ac.uk
Journal
BMJ. 2008 Aug 21;337:a993. doi: 10.1136/bmj.a993.

17. Aortic sclerosis, aortic stenosis and lipid-lowering therapy.

Author
Rosenhek R; Baumgartner H;
Institution
Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Wien, Austria. raphael.rosenhek@meduniwien.ac.at
Journal
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):385-90.
Abstract URL
Click here to view abstract

18. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.

Author
Kesaniemi A;
Institution
Department of Internal Medicine, Oulu University Hospital, Oulu, Finland. ayk@sun3.oulu.fi
Journal
Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:29-30.
Abstract URL
Click here to view abstract

19. New targets and emerging therapies for reducing LDL cholesterol.

Author
Lilly SM; Rader DJ;
Institution
Department of Medicine and Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Journal
Curr Opin Lipidol. 2007 Dec;18(6):650-5.
Abstract URL
Click here to view abstract

20. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.

Author
Sweeney ME; Johnson RR;
Institution
Emory University School of Medicine, Division of Endocrinology, Metabolism and Lipids, Atlanta VA Medical Center-111, 1670 Clairmont Rd, Atlanta, GA 30033, USA. msweene@emory.edu
Journal
Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):441-50.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6